Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: Analysis of 19 patients from the BFM trials

Medical and Pediatric Oncology

Volumn 33, Issue 6, 1999, Pages 536-544

  Seidemann, Kathrin ^a   Tiemann, Markus ^b   Henze, Günter ^c   Sauerbrey, Axel ^d   Müller, Susanna ^e   Reiter, Alfred ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Childhood; Chromosome breakage syndrome; Non Hodgkin lymphoma (NHL); Primary immunodeficiency; Therapy

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE; VINDESINE;

ADOLESCENT; ADULT; ANTIGENICITY; ARTICLE; CANCER SURVIVAL; CHILD; CHROMOSOME BREAKAGE; DATA ANALYSIS; DOSE RESPONSE; DRUG EFFECT; FEMALE; GENE REARRANGEMENT; HUMAN; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; LYMPHOMA, T-CELL; PROSPECTIVE STUDIES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 0032728442     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199912)33:6<536::AID-MPO3>3.0.CO;2-Z     Document Type: Article

References (41)

1. Filipovich AH, Mathur A, et al. Lymphoroliferative disorders and other tumors complicating immunodeficiency. Immunodeficiency 1994;5:91-112.
2. Meyn MS. Chromosome instability syndromes: lessons for carcinogenesis. Curr Top Microbiol Immunol 1987;221:72-148.
3. Morrell D, Cromartie E, Swift M. Mortality and cancer incidence in 236 patients with ataxia teleangiectasia. J Natl Cancer Inst 1986;77:89-92.
4. Hong D-S, Beckham C, Huss R, et al. Major histocompatibility complex class II-mediated inhibition of hematopoiesis in long-term marrow cultures involves apoptosis and is prevented by c-kit ligand. Blood 1995;86:3341-3352.
5. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P. Incidence of cancer in 98 patients with common variable immunideficiency. J Clin Immunol 1993;7:294-301.
6. Filipovich AH, Mertens A, Robison L, et al. Lymphoproliferative disorders associated with primary immunodeficiencies. In: Magrath I, editor. The non-Hodgkin's lymphomas, 2nd ed. London: Arnold; 1997. p 459-471.
7. Filipovich AH. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res 1992;52:5465-5467.
8. Taylor AMR, Metcalfe JA, Thick J, Mak Y-F. Leukemia and lymphoma in ataxia teleangiectasia. Blood 1996;87:423-438.
9. Green AJ, Yates JRW, Taylor AMR, et al. Severe microcephaly with normal intellectual development: the Nijmegen breakage syndrome. Arch Dis Child 1995;73:431-434.
10. Chrzanowska KH, Kleijer WJ, Krajewska-Walasek M, et al. Eleven patients with microcephaly, immunodeficiency, and chromosomal instability: the Nijmegen breakage syndrome. Am J Med Gen 1995;57:462-471.
11. Schulte Overbeck-Schmidt U, Wegner RD, Baumgarten RD, et al. Low-grade non-Hodgkin's lymphoma after high-grade non-Hodgkin's lymphoma in a child with ataxia teleangiectasia. Cancer 1994;73:1522-1525.
12. Cunningham-Rundles C, Liebermann G, Hellmann G, Chaganti RSK. Non-Hodgkin's lymphoma in common variable immunodeficiency. Am J Hematol 1991;37:69-74.
13. Oxelius V. IgG subclass patterns in primary immunodeficiency disorders. Monogr Allerg 1986;19:156-163.
14. Shield JPH, Strobel S, Levinsky RJ, Morgan G. Immunodeficiency presenting as hypergammaglobulinernia with IgG2 subclass deficiency. Lancet 1992;340:448-451.
15. Buckley RH. Breakthroughs in the understanding and therapy of primary immunodeficiency. Pediatr Clin North Am 1994;41:665-690.
16. Bundey S. Clinical and genetic features of ataxia teleangiectasia. Int J Radiat Biol 1994;66:23-29.
17. Jaspers NG, Gatti RA, Baan C, et al. Genetic complementation analysis of ataxia teleangiectasia and Nijmegen breakage syndrome: a survey of 50 patients. Cytogenet Cell Genet 1998;49: 259-263.
18. Seemanova E. An increased risk for malignant neoplasms in heterozygotes for a syndrome of microcephaly, normal intelligence, growth retardation, remarkable faces, immunodeficiency and chromosomal instability. Mutat Res 1990;238:321-324.
19. Borisch-Chappuis B, Nezelof C, Müller H, Müller-Hermelink HK. Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients. Am J Pathol 1990;136:751-758.
20. Purtilo DT, Falk K, Pirruccello SJ, et al. SCID mouse model of Epstein-Barr virus-induced lymphomagenesis of immundeficient humans. Int J Cancer 1991;47:510-517.
21. Grierson HL, Skare J, Hawk J, et al. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease. Am J Med Genet 1991;40:294-297.
22. Kammermeier-Schmidt U, Weiss M, Belohradsky BH. Das X-chromosomal vererbte lymphoproliferative Syndrom (XLP). Monatsschr Kinderheilkd 1993;141:201-206.
23. Hong R. Update on immunodeficiency disease. Am J Dis Child 1990;114:983-992.
24. Lennert K, Feller AC. In: Lennert K, Feller AC, editors. Histopathologie der Non-Hodgkin-Lymphome, 2nd ed. Berlin: Springer; 1990.
25. Stansfeld AG, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988;1:292-293.
26. Harris NL. Principles of the revised European-American Lymphoma classification (from the International Lymphoma Study Group). Ann Oncol 1997;8(2):11-16.
27. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1997;84:1361-1392.
28. Bennett JM, Catorsky D, Daniel MT, et.al. Proposal for the classification of the acute leukemias. French-American-British (FAB) Cooperative Groups. Br J Heamatol 1976;33:451-458.
29. Reiter A, Schrappe M, Parwaresch R, et al. Non-Hodgkin's lymphomas of childhood an adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Münster Group. J Clin Oncol 1995;13:359-372.
30. Ludwig WD, Bartram CR, Ritter J. Ambiguous phenotypes and genotypes in 16 children as characterized by multiparameter analysis. Blood 1988;71:1518-1528.
31. Cartun RW, Coles FB, Pastuszak WT. Utilization of a monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalinand B5-fixed, paraffin-embedded tissues. Am J Pathol 1987;129: 415-421.
32. Hansmann ML, Wacker HH, Gralla J, et al. KiB5: a monoclonal antibody unrelated to CD45 recognizes normal and neoplastic B-cells in routine paraffine sections. Blood 1991;77:809-817.
33. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
34. Schwarting R, Gerdes J, Durkop H, et al. BerH2: a new anti-Ki1 (CD30) monoclonal antibody directed at a formalin-resistant epitope. Blood 1989;74:1678-1689.
35. Murphy SB. Classification, staging and end results of treatment in childhood non-Hodgkin's lymphoma: dissimilarities from lymphomas in adults. Semin Oncol 1980;7:332-339.
36. Van de Kaa CA, Weemaes CMR, Wesseling P, et al. Postmortem findings in the Nijmegen breakage syndrome. Pediatr Pathol 1994; 14:787-796.
37. Weemaes CMR, Smeets DFCM, van der Burgt CJAM. Nijmegen syndrome: a progress report. Int J Radial Biol 1994;66:185-188.
38. Swift M, Morrell D, Massey RB, Chase CL. Incidence of cancer in 161 families affected by ataxia teleangiectasia. N Engl J Med 1991;325:1831-1836.
39. Fresno: a phenotype linking ataxia teleangiectasia with the Nijmegen breakage syndrome. Am J Hum Genet 1989;45:270-275.
40. Dluzniewska A, Tredowska-Skoczen D, Armata J, Tacik J. Microcephaly and childhood non-Hodgkin's lymphoma. Arch Dis Child 1995;73:480-481.
41. Huo YK, Wang Z, Hong JH, et al. Radiosensitivity of ataxia teleangiectasia, X-linked agammaglobulinemia, and related syndromes using a modified colony survival assay. Cancer Res 1994; 54:2544-2547.